NDC 0074-0038 – Orilissa
Elagolix Sodium 150 mg/1 · Tablet, Film Coated · Oral
Product NDC0074-0038
Product details
- Brand name
- Orilissa
- Generic name
- Elagolix
- Labeler
- AbbVie Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA210450
- Marketed since
- July 23, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Gonadotropin Releasing Hormone Receptor Antagonist
Active ingredients
- Elagolix Sodium 150 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0074-0038-07 sample | 1 BLISTER PACK in 1 CARTON (0074-0038-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK | Jul 23, 2018 |
| 0074-0038-28 | 4 BLISTER PACK in 1 CARTON (0074-0038-28) / 7 TABLET, FILM COATED in 1 BLISTER PACK | Jul 23, 2018 |
Recalls mentioning this NDC
- D-0403-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Orilissa products
- 0074-0039 Elagolix Sodium 200 mg/1 · Tablet, Film Coated · AbbVie Inc.